The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: Its regulation by interferon γ and interleukin-10

Cancer Immunology Immunotherapy

Volumn 43, Issue 4, 1996, Pages 213-219

  Li, Jian ^a   Yang, Yi ^a   Inoue, Hiroshi ^a   Mori, Masaki ^a   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CD80; CD86; cytokine; human carcinoma cell line; mRNA

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA;

ARTICLE; CELL LINE; FLOW CYTOMETRY; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; FLOW CYTOMETRY; GASTROINTESTINAL NEOPLASMS; HEMATOLOGIC NEOPLASMS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; MEMBRANE GLYCOPROTEINS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0030466728     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050324     Document Type: Article

References (40)

1. Antonia SJ, Munoz-Antonia T, Soldevila G, Miller J, Fravill RA (1995) B7-1 expression by a non-antigen presenting cell-derived tumor. Cancer Res 55: 2253
2. Aragane Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Lugar TA, Kubin M, Trinchieri G, Schwarz T (1994) IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 153: 5366
3. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366: 76
4. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL (1993) Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 177: 845
5. Baskar S, Ostrand-Rosenberg S, Navabi N, Nadler LM, Freeman GJ, Glimcher LH (1993) Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 90: 5687
6. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM (1993) Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulates T-cell activation. Proc Natl Acad Sci USA 90: 11059
7. Chang C-H, Furue M, Tamaki K (1995) B7-1 expression on Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or interleukin-10. Eur J Immunol 25: 394
8. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocytes molecules CD28 and CTLA-4. Cell 71: 1093
9. Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellstrom I, Hellstrom KE (1994) Tumor immunogenecity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med 179: 523
10. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156
11. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schopf E, Simon JC (1995) In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell mediated anti-tumor immunity. Int J Cancer 62: 259
12. Ding L, Linsley PS, Juang L-Y, Germain RN, Shevach EM (1993) IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151: 1224
13. Dohring C, Angman L, Spagnoli G, Lavanzavecchia A (1994) T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int J Cancer 57: 754
14. Dustin ML, Rothlin R, Bhan AK, Dinarello CA, Springer TA (1986) Inductin by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245
15. Freedman AS, Freedman JG, Horowitz JC, Daley J, Nadler LM (1987) B7, a B cell-restricted antigen that identifies preactivated B cells. J Immunol 139: 3260
16. Freedman AS, Freedman JG, Rhynhart K, Nadler LM (1991) Selective induction of B7/BB1 on interferon gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 137: 429
17. Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM (1991) Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 174: 652
18. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM (1993) Cloning of B7-2: a CTLA-4 counter-receptor that stimulates human T cell proliferation. Science 262: 909
19. Gajewski TF, Fallarino F, Uyttenhove C, Boon T (1996) Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor. Superiority of B7-1 over B7-2 for active tumor immunization. J Immunol 156: 2909
20. Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, Chen M, Albino AP, Bander NH (1993) Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55: 96
21. Gaudagni F, Schlom J, Johnston WW, Szpak CA, Goldstein D, Smalley R, Simpson JF, Borden EC, Pestka S, Greiner JW (1989) Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells. J Natl Cancer Inst 81: 502
22. Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freedman AS, Morimoto C, Nadler LM (1991) B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 88: 6575
23. Hart DN, Starling GC, Calder VL, Fernando NS (1993) B7/BB1 is a leukocyte differentiation antigen on human dendritic cells induced by activation. Immunology 79: 616
24. Hathcock KS, Laszlo G, Pecillo C, Linsley P, Hodes RJ (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180: 631
25. Hersey P, Si ZY, Smith MJ, Thomas WD (1994) Expression of the costimulatory molecule B7 on melanoma cells. Int J Cancer 58: 527
26. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707
27. Lanier LL, O'Fall S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M (1995) CD80(B7) and CD86(B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154: 97
28. Lenschow DJ, Sperling AI, Cooke MP, Freeman G, Rhee L, Decker DC, Gray G, Nadler LM, Goodnow C, Bleustone JA (1994) Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol 153: 1990
29. + T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J Immunol 153: 421
30. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173: 721
31. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174: 561
32. Matsuda M, Salazar-Onfray F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang Q-J, Masucci MG, Kiessling R (1994) Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180: 2371
33. McMillan DN, Kernohan NM, Flett ME, Heys SD, Deeham DJ, Sewell HF, Walker F, Eremin O (1995) Interleukin-2 receptor expression and interleukin-2 localization in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumor cell proliferation. Int J Cancer 60: 766
34. Ozawa H, Aiba S, Nakagawa S, Tagami H (1996) Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur J Immunol 26: 648
35. Ramarathinam L, Castle M, Wu Y, Lie Y (1994) T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med 179: 1205
36. Rosa F, Fellous M (1984) The effect of gamma-interferon on MHC antigens. Immunol Today 5: 261
37. + T cells by B7-transfected melanoma cells. Science 259: 358
38. Willems F, Marchant A, Delville J-P, Gerand C, Delvaux A, Velu T, De Boer M, Goldman M (1994) Interleukin-10 inhibits B7 and intracellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24: 1007
39. Yang G, Hellstrom KE, Hellstrom I, Chen L (1995) Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J Immunol 154: 2794
40. Yokochi T, Holly RD, Clark SD (1982) Lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines and Burkitt's lymphomas. J Immunol 128: 823